SARS-CoV-2 Cell Entry Depends On ACE2 And TMPRSS2 And Is Blocked By A Clinically Proven Protease Inhibitor

·2020·DOI

Health Sciences and Innovation

Biomedical Engineering

Infectious Disease and Immunology

Real-Time PCR and MicroRNA

Abstract

Citations

16,717

Year

2020

PageRank

5.3 / 10

Relative influence (log-scaled)